Tianjin, China – September 28, 2022 – Genobio Pharmaceutical Co., Ltd, a wholly-owned subsidiary of Era Biology Group, which is a leader and pioneer of invasive fungal disease diagnostic field sinc...
Meeting Era Biology at ECCMID 2023
The ECCMID congress, the Annual Congress of Clinical Microbiology and Infectious Diseases, is one of the most important events in the field of clinical microbiolo...
The genomic sequences of most viruses have been known. Nucleic acid probes which are short segments of DNA designed to hybridize with complementary viral DNA or RNA segments . The polymerase chain...
On June 7th, Era Biology hosted a live webinar for Latin America. The webinar focuses on antimicrobial resistance problem. Since 2005, the antibiotic resistance rate of bacteria has been increasing...
FACIS Successfully Approved by Health Canada
We are glad to announce that the Full-Automatic Chemiluminescence Immunoassay System (FACIS), with its adaptable reagents the Aspergillus Galactomannan ...
Meet Era Biology at Africa Health 2022
The 11th annual Africa Health 2022 exhibition will be held in Gallagher Convention Center, Johannesburg, South Africa on 26th-28th October.
Africa Health is t...